Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1998 Jul;89(7):757–767. doi: 10.1111/j.1349-7006.1998.tb03281.x

Release of Cytokines from Human Umbilical Vein Endothelial Cells Treated with Platinum Compounds in vitro

Yucheng Shi 1, Shoichi Inoue 1,✉, Reiko Shinozaki 1, Kaoru Fukue 1, Tohru Kougo 2
PMCID: PMC5921881  PMID: 9738983

Abstract

Endothelial cells (EC) produce cytokines, such as interleukin (IL)‐1, IL‐6, IL‐8 and granulocyte‐macrophage colony‐stimulating factor (GM‐CSF). These cytokines have an important role in the proliferation and differentiation of hematopoietic progenitor cells. On the other hand, anticancer agents generally cause hematopoietic disorders. However, little is known about the effects of chemotherapeutic agents on the secretion of cytokines from EC. Therefore, we investigated if treatment with platinum compounds may stimulate EC to secrete cytokines. EC newly isolated from a human umbilical vein were exposed to cisplatin, carboplatin, or TRK‐710 for 80 min, then the cells were washed and placed in fresh medium. The levels of cytokines in the fresh medium were measured by the ELISA method, the levels of intracellular hydrogen peroxide (H2O2) were measured by flow cytometry, and the rhodamine 123‐stained live mitochondria of the EC were observed under a confocal laser microscope. Platinum compounds induced cytokine production in human EC: cisplatin most prominently induced the release of IL‐1 and IL‐6, and TRK‐710 had the greatest ability to induce the release of GM‐CSF. Intracellular H2O2 production and IL‐8 release were transiently induced immediately after treatment with platinum compounds, leading to IL‐1 release when H2O2 production was eliminated. These results may provide new insights into the hematological toxicity induced by anticancer agents and the role of IL‐1 and IL‐6 secreted from EC in this toxicity.

Keywords: key words, Cytokine, Hydrogen peroxide, Endothelial cell, Platinum compound

Full Text

The Full Text of this article is available as a PDF (526.0 KB).

REFERENCES

  • 1. ) Shepro , D. and Morel , N. M. L.Pericyte physiology . FASEB J. , 7 , 1031 – 1038 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) McMillen , M. A. , Huribal , M. and Sumpio , B.Common pathway of endothelial‐leukocyte interaction in shock, ischemia, and reperfusion . Am. J. Surg. , 166 , 557 – 562 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Ley , K.Molecular mechanisms of leukocyte recruitment in the inflammatory process . Cardiovasc. Res. , 32 , 733 – 742 ( 1996. ). [PubMed] [Google Scholar]
  • 4. ) Risau , W.Differentiation of endothelium . FASEB J. , 9 , 926 – 933 ( 1995. ). [PubMed] [Google Scholar]
  • 5. ) Pomerat , C. M. and Slick , W. C.Isolation and growth of endothelial cells in tissue culture . Nature , 198 , 859 – 861 ( 1963. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Fryer , D. G. , Birnbaum , G. and Luttrell , C. N.Human endothelium in cell culture . J. Atheroscler. Res. , 6 , 151 – 163 ( 1966. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Yoshizumi , M. , Kurihara , H. , Morita , T. , Yamashita , T. , Oh‐hashi , Y. , Sugiyama , T. , Takaku , F. , Yanagisawa , M. , Masaki , T. and Yazaki , Y.Interleukin 1 increases the production of endothelin‐1 by cultured endothelial cells . Biochem. Biophys. Res. Commun. , 166 , 324 – 329 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Yonemura , Y. , Ku , H. , Hirayama , F. , Souza , L. M. and Ogawa , M.Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells . Proc. Natl. Acad. Sci. USA , 93 , 4040 – 4044 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. ) Shalaby , M. R. , Waage , A. and Espevik , T.Cytokine regulation of interleukin 6 production by human endothelial cells . Cell. Immunol. , 121 , 372 – 382 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Sironi , M. , Breviario , F. , Proserpio , P. , Biondi , A. , Vecchi , A. , Van Damme , J. , Dejana , E. and Mantovani , A.IL‐1 stimulates IL‐6 production in endothelial cells . J. Immunol. , 142 , 549 – 553 ( 1989. ). [PubMed] [Google Scholar]
  • 11. ) Ikebuchi , K. , Wong , G. G. , Clark , S. C. , Ihle , J. N. , Hirai , Y. and Ogawa , M.Interleukin 6 enhancement of interleukin 3‐dependent proliferation of multipotential hemopoietic progenitors . Proc. Natl. Acad. Sci. USA , 84 , 9035 – 9039 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. ) Morsey , M. A. , Popowych , Y. , Kowalski , J. , Gerlach , G. , Godson , D. and Campos , M.Molecular cloning and expression of bovine interleukin 8 . Microb. Pathog. , 20 , 203 – 212 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Strieter , R. M. , Kunkel , S. L. , Schowell , H. J. and Marks , R. M.Monokine‐induced gene expression of a human endothelial cell derived neutrophil chemotactic factor . Biochem. Biophys. Res. Commun. , 156 , 1340 – 1345 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Gimbrone , M. A. , Jr. , Obin , M. S. , Brock , A. F. , Luis , E. A. , Hass , P. E. , Hebert , C. A. , Yip , Y. K. , Leung , D. W. , Lowe , D. G. , Kohr , W. J. , Darbonne , W. C. , Bechtol , K. B. and Baker , J. B.Endothelial interleukin‐8: a novel inhibitor of leukocyte‐endothelial interactions . Science , 246 , 1601 – 1603 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Colditz , I. , Zwahlen , R. , Dewald , B. and Baggiolini , M.In vivo inflammatory activity of neutrophil‐activating factor, a novel chemotactic peptide derived from human monocytes . Am. J. Pathol. , 134 , 755 – 760 ( 1989. ). [PMC free article] [PubMed] [Google Scholar]
  • 16. ) O'Flaherty , J. T. , Showell , H. J. and Ward , P. A.Neutro‐penia induced by systemic infusion of chemotactic factors . J. Immunol. , 118 , 1586 – 1589 ( 1977. ). [PubMed] [Google Scholar]
  • 17. ) Obin , M. S. , Kiely , J. M. , Hebert , C. , Baker , J. and Gimbrone , M. A. , Jr.Endothelial interleukin‐8: a novel inhibitor of leukocyte adhesion . FASEB J. , 4 , A625 ( 1977. ). [Google Scholar]
  • 18. ) Donahue , R. E. , Emerson , S. G. , Wang , E. A. , Wong , G. G. , Clark , S. C. and Nathan , D. G.Demonstration of burst‐promoting activity of recombinant human GM‐CSF on circulating erythroid progenitors using an assay involving the delayed addition of erythropoietin . Blood , 66 , 1479 – 1481 ( 1985. ). [PubMed] [Google Scholar]
  • 19. ) Emerson , S. G. , Sieff , C. A. , Wang , E. A. , Wong , G. G. , Clark , S. C. and Nathan , D. G.Purification of fetal hematopoietic progenitors and demonstration of recombinant multipotential colony‐stimulating activity . J. Clin. Invest. , 76 , 1286 – 1290 ( 1985. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. ) Sieff , C. A. , Emerson , S. G. , Donahue , R. E. , Nathan , D. G. , Wang , E. A. , Wong , G. G. and Clark , S. C.Human recombinant granulocyte‐macrophage colony‐stimulating factor: a multilineage hematopoietin . Science , 230 , 1171 – 1173 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Sieff , C. A. , Emerson , S. G. , Mufson , A. , Gesner , T. G. and Nathan , D. G.Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin . J. Clin. Invest. , 77 , 74 – 81 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. ) Baker , F. L. , Broxmeyer , H. E. and Galbraith , P. R.Control of granulopoiesis in man. III. Inhibition of colony formation by dense leukocytes . J. Cell. Physiol. , 86 , 337 – 342 ( 1975. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Weisbart , R. H. , Golde , D. W. , Clark , S. C. , Wong , G. G. and Gasson , J. C.Human granulocyte‐macrophage colony‐stimulating factor is a neutrophil activator . Nature , 314 , 361 – 363 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Jaswon , M. S. , Khwaja , A. , Roberts , P. J. , Jones , H. M. and Linch , D. C.The effects of rhGM‐CSF on the neutrophil respiratory burst when studied in whole blood . Br. J. Haematol. , 75 , 181 – 187 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Taylor , S. G. , IVHead and neck cancer . In“Cancer Chemotherapy,” ed. Pinedo H. M. , pp. 291 – 306 ( 1979. ). Elsevier; , Amsterdam . [Google Scholar]
  • 26. ) Bradner , W. T. , Rose , W. C. and Huftalen , J. B.Antitumor activity of platinum analogs . In“Cisplatin: Current Status and New Developments,” ed. Prestayko A. W. , Crooke S. T. and Carler S. K. , pp. 171 – 182 ( 1980. ). Academic Press; , New York . [Google Scholar]
  • 27. ) Calvert , A. H. , Harland , S. J. , Newell , D. R. , Siddik , Z. H. , Jones , A. C. , McElwain , T. J. , Raju , S. , Wiltshaw , E. , Smith , I. E. , Baker , J. M. , Peckham , M. J. and Harrap , K. R.Early clinical studies with cis‐diammine‐1,1‐cyclo‐butane dicarboxylato platinum II . Cancer Chemother. Pharmacol. , 9 , 140 – 147 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Rozencweig , M. , Nicaise , C. , Beer , M. , Crespeigne , N. , Van Rijmenant , M. , Lenaz , L. and Kenis , Y.Phase I study of carboplatin given on a five‐day intravenous schedule . J. Clin. Oncol. , 1 , 621 – 626 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Van Echo , D. A. , Egorin , M. J. , Whitacre , M. Y. , Olman , E. A. and Aisner , J.Phase I clinical and pharmacologic trial of carboplatin daily for 5 days . Cancer Treat. Rep. , 68 , 1103 – 1114 ( 1984. ). [PubMed] [Google Scholar]
  • 30. ) Saito , T. , Manabe , Y. and Saito , H.Ototoxicity of the new platinum anticancer agent TRK‐710 in comparison with cisplatin . ORL ( Basel ), 57 , 250 – 255 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 31. ) Hoagland , H. C.Hematologic complications of cancer chemotherapy . In“The Chemotherapy Source Book,” ed. Perry M. C. , pp. 498 – 507 ( 1992. ). Williams & Wilkins; , Baltimore . [Google Scholar]
  • 32. ) Nicosia , R. F. , Villaschi , S. and Smith , M.Isolation and characterization of vasoformative endothelial cells from the rat aorta . In Vitro Cell Dev. Biol. Anim. , 30A , 394 – 399 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Ratain , M. J. and Schisky , R. L.Principles of pharmacology and phamacokinetics . In“The Chemotherapy Source Book,” ed. Pery M. C. , pp. 22 – 35 ( 1992. ). Williams & Wilkins; , Baltimore . [Google Scholar]
  • 34. ) Yamamoto , N. , Tamura , T. , Maeda , M. , Ando , M. , Shinkai , T. , Eguchi , K. , Ohe , Y. , Oshita , F. , Shiraishi , J. T. , Katsumata , N. and Saijo , N.The influence of ageing on cisplatin pharmacokinetics in lung cancer patients with normal organ function . Cancer Chemother. Pharmacol. , 36 , 102 – 106 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 35. ) Oguri , S. , Sakakibara , T. , Mase , H. , Shimizu , T. , Ishikawa , K. , Kimura , K. and Smyth , R. D.Clinical pharmacokinetics of carboplatin . J. Clin. Pharmacol. , 28 , 208 – 215 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 36. ) Yuan , L. , Inoue , S. , Saito , Y. and Nakajima , O.An evaluation of the effects of cytokines on intracellular oxidative production in normal neutrophils by flow cytometry . Exp. Cell Res. , 209 , 375 – 381 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 37. ) Inoue , S. , Mizuno , S. , Ito , M. and Ohnuma T.Flow cytometric analyses of the characteristics of tumor cells treated with two platinum compounds: 1,1‐cyclobutanedicarboxyl‐ato(2‐aminomethylpyrrolidine)platinum(II) and cisplatin . Jpn. J. Cancer Res. , 83 , 1231 – 1240 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. ) Booyse , F. M. , Sedlak , B. J. and Rafelson , M. E.Culture of arterial endothelial cells: characterization and growth of bovine aortic cells . Thromb. Diath. Haemorrh. , 34 , 825 – 839 ( 1975. ). [PubMed] [Google Scholar]
  • 39. ) Baggiolini , M. , Walz , A. and Kunkel , S. L.Neutrophil‐activating peptide‐1/interleukin 8, a novel cytokine that activates neutrophils . J. Clin. Invest. , 84 , 1045 – 1049 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. ) Nakata , T. , Suzuki , K. , Fujii , J. , Ishikawa , M. and Taniguchi N.Induction and release of manganese superoxide dismutase from mitochondria of human umbilical vein endothelial cells by tumor necrosis factor‐α and inter‐leukin‐1α . Int. J. Cancer , 55 , 646 – 650 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 41. ) Taniguchi , N.Clinical significances of superoxide dismutases: changes in aging, diabetes, ischemia, and cancer . In“Advances in Clinical Chemistry,” ed. Spiegel E. H. , Vol. 29 , pp. 1 – 59 ( 1992. ). Academic Press; , San Diego . [DOI] [PubMed] [Google Scholar]
  • 42. ) Ono , M. , Kohda , H. , Kawaguchi , T. , Ohhira , M. , Sekiya , C. , Namiki , M. , Takeyasu , A. and Taniguchi , N.Induction of Mn‐superoxide dismutase by tumor necrosis factor, interleukin‐1 and interleukin‐6 in human hepatoma cells . Biochem. Biophys. Res. Commun. , 182 , 1100 – 1107 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 43. ) Prajda , N. , Kralovanszky , J. , Gal , F. , Kiss , F. and Kerpel Fronius , S.Evaluation of side effects of platinum complexes (CDDP, CBDCA, CHIP) on bone marrow . In Vivo , 3 , 267 – 270 ( 1989. ). [PubMed] [Google Scholar]
  • 44. ) Keating , M. J. , Estey , E. and Kantarjian , H.Acute leukemia . In“Cancer: Principles and Practice of Oncology,” Vol. 2 , 4th Ed. , ed. DeVita V. T., Jr. , Hellman S. and Rosenberg S. A. , pp. 1938 – 1964 ( 1993. ). Lippincott; , Philadelphia . [Google Scholar]
  • 45. ) Mochizuki , D. Y. , Eisenman , J. R. , Conlan , P. J. , Larsen , A. D. and Tushinski , R. J.Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1 . Proc. Natl. Acad. Sci. USA , 84 , 5267 – 5370 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. ) Bruno , E. and Hoffman , R.Effect of interleukin‐6 on in vitro human megakaryocytopoiesis: its interaction with other cytokines . Exp. Hematol. , 17 , 1038 – 1042 ( 1989. ). [PubMed] [Google Scholar]
  • 47. ) Weisdorf , D. , Katsanis , E. , Verfaillie , C. , Ramsay , N. K. C. , Haake , R. , Garrison , L. and Blazar , B. R.Interleukin‐1 alpha administered after autologous transplantation: a phase I/II clinical trial . Blood , 84 , 2044 – 2049 ( 1994. ). [PubMed] [Google Scholar]
  • 48. ) Triozzi , P. L. , Kim , J. A. , Martin , E. W. , Youg , D. C. , Benzies , T. and Villasmil , P. A.Phase I trial of escalating doses of interleukin‐1β in combination with a fixed dose of interkeukin‐2 . J. Clin. Oncol. , 13 , 482 – 489 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 49. ) Engerman , R. L. , Pfaffenbach , D. and Davis , M. D.Cell turnover of capillaries . Lab. Invest. , 17 , 738 – 743 ( 1967. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES